Literature DB >> 20458601

Cbl-b in T-cell activation.

Magdalena Paolino1, Josef M Penninger.   

Abstract

Peripheral activation of antigen-specific T cells is stringently controlled to prevent immune responses against self-antigens. Only after a T cell is presented with two signals, an antigen and a co-stimulatory signal, can they be fully activated. In case antigen presentation occurs without co-stimulation, T-cell receptor (TCR) signaling pathways are regulated to prevent T-cell activation and induce T-cell tolerance. Thus, for a productive T-cell response to occur, co-stimulatory receptors need to serve the dual role of amplifying the TCR signaling while concomitantly releasing T cells from suppression. Biochemical and genetic studies during the last 10 years have documented the critical role of the E3 ubiquitin-ligase Cbl-b in this fundamental two-signal modulation of T-cell responses. In this review, we will discuss our current understanding on how Cbl-b controls T-cell activation and tolerance, its in vivo implications, as well as mechanisms for tuning T-cell-mediated immune responses by this essential E3 ligase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458601     DOI: 10.1007/s00281-010-0197-9

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  102 in total

1.  Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.

Authors:  D Fang; H Y Wang; N Fang; Y Altman; C Elly; Y C Liu
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

Review 2.  CD28-mediated co-stimulation: a quantitative support for TCR signalling.

Authors:  Oreste Acuto; Frédérique Michel
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

3.  Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.

Authors:  Xiujuan Qu; Kiyonao Sada; Shinkou Kyo; Koichiro Maeno; S M Shahjahan Miah; Hirohei Yamamura
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

4.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

Review 5.  NFAT proteins: key regulators of T-cell development and function.

Authors:  Fernando Macian
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

Review 6.  Ubiquitin and ubiquitin-like proteins as multifunctional signals.

Authors:  Rebecca L Welchman; Colin Gordon; R John Mayer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

7.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

8.  Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.

Authors:  C Elly; S Witte; Z Zhang; O Rosnet; S Lipkowitz; A Altman; Y C Liu
Journal:  Oncogene       Date:  1999-02-04       Impact factor: 9.867

9.  Ablation of Cbl-b provides protection against transplanted and spontaneous tumors.

Authors:  Jeffrey Y Chiang; Ihn Kyung Jang; Richard Hodes; Hua Gu
Journal:  J Clin Invest       Date:  2007-03-15       Impact factor: 14.808

10.  Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene.

Authors:  M M Keane; O M Rivero-Lezcano; J A Mitchell; K C Robbins; S Lipkowitz
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

View more
  21 in total

1.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

2.  Impairment of non-muscle myosin IIA in human CD4+ T cells contributes to functional deficits in the elderly.

Authors:  Stefania Cane; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Cell Mol Immunol       Date:  2011-10-10       Impact factor: 11.530

3.  CBLB Constrains Inactivated Vaccine-Induced CD8+ T Cell Responses and Immunity against Lethal Fungal Pneumonia.

Authors:  Som G Nanjappa; Srinivasu Mudalagiriyappa; J Scott Fites; M Suresh; Bruce S Klein
Journal:  J Immunol       Date:  2018-07-27       Impact factor: 5.422

4.  T Cells Deficient in the Tyrosine Phosphatase SHP-1 Resist Suppression by Regulatory T Cells.

Authors:  Emily R Mercadante; Ulrike M Lorenz
Journal:  J Immunol       Date:  2017-05-26       Impact factor: 5.422

5.  In vivo discovery of immunotherapy targets in the tumour microenvironment.

Authors:  Penghui Zhou; Donald R Shaffer; Diana A Alvarez Arias; Yukoh Nakazaki; Wouter Pos; Alexis J Torres; Viviana Cremasco; Stephanie K Dougan; Glenn S Cowley; Kutlu Elpek; Jennifer Brogdon; John Lamb; Shannon J Turley; Hidde L Ploegh; David E Root; J Christopher Love; Glenn Dranoff; Nir Hacohen; Harvey Cantor; Kai W Wucherpfennig
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

6.  Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling.

Authors:  Akhee S Jahan; Maxime Lestra; Lee Kim Swee; Ying Fan; Mart M Lamers; Fikadu G Tafesse; Christopher S Theile; Eric Spooner; Roberto Bruzzone; Hidde L Ploegh; Sumana Sanyal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

Review 7.  Ubiquitin ligases in cancer: Functions and clinical potentials.

Authors:  Shanshan Duan; Michele Pagano
Journal:  Cell Chem Biol       Date:  2021-05-10       Impact factor: 9.039

Review 8.  Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy.

Authors:  Xiaoli Hu; Jing Wang; Man Chu; Yi Liu; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Mol Ther       Date:  2021-01-01       Impact factor: 11.454

9.  Agelasine Diterpenoids and Cbl-b Inhibitory Ageliferins from the Coralline Demosponge Astrosclera willeyana.

Authors:  Wei Jiang; Dongdong Wang; Brice A P Wilson; Unwoo Kang; Heidi R Bokesch; Emily A Smith; Antony Wamiru; Ekaterina I Goncharova; Donna Voeller; Stanley Lipkowitz; Barry R O'Keefe; Kirk R Gustafson
Journal:  Mar Drugs       Date:  2021-06-24       Impact factor: 5.118

10.  Tumor rejection in Cblb -/- mice depends on IL-9 and Th9 cells.

Authors:  Oliver Schanz; Isabelle Cornez; Sowmya Parampalli Yajnanarayana; Friederike Sophie David; Sebastian Peer; Thomas Gruber; Peter Krawitz; Peter Brossart; Annkristin Heine; Jenny Landsberg; Gottfried Baier; Dominik Wolf
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.